Skip to main content
Juan Sanchez-Ramos, MD, Neurology, Tampa, FL

JuanSanchez-RamosMD

Neurology Tampa, FL

Professor Emeritus, Department of Neurology at USF; Past-Director, Huntington Disease Center of Excellence,

Dr. Sanchez-Ramos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sanchez-Ramos' full profile

Already have an account?

  • Office

    12901 Bruce B Downs Blvd
    Mdc 55
    Tampa, FL 33612
    Phone+1 813-974-6022

Summary

  • Dr. Juan (Zeno) Sanchez-Ramos, PhD, MD is Professor Emeritus in the Dept of Neurology, University of South Florida. He held the Helen Ellis Endowed Chair from 1996 until retirement in 2024. He is a physician-scientist who received a Ph.D. in Pharmacology and Physiology from the University of Chicago and a medical degree (M.D.) from the University of Illinois. He trained in Neurology at the University of Chicago and as a Fellow in Movement Disorders at the University of Miami. His neuroscience research has included studies of drug dependence, toxicant-induced neurodegeneration, stem cell biology, botanical medications and novel approaches for delivery of gene therapy. He was a member of a team of neurologists, psychologists and geneticists that studied a large Venezulean family with Huntington’s Disease (HD). Based on that extensive field work, the research team discovered the HD gene in 1992. He has served as the Director of the Huntington’s Disease Center of Excellence at USF since 2006 and Director of the Parkinson’s Disease Research Foundation (Sarasota) for 10 years. He has served as Art Editor of Chicago Review, and has illustrated medical publications. He received an Award for his animation entitled “Dancing DNA” sponsored by the University of Chicago Materials Research Center in their annual Sights and Sounds of Science Project (2004). He has received numerous awards including an NIH Clinical Investigator Development Award to start his research lab, the Helen E. Ellis Endowed Chair for Parkinson's Disease Research, USF McNair Scholars Faculty Research Mentor Award, and the University of South Florida Outstanding Faculty Research Achievement Award. He has been awarded 8 US patents including a novel method to treat drug dependence, a method for development of neural cells from bone marrow-derived stem cells, and a novel nanoparticle system to allow nose-to-brain delivery of gene therapy. Publications: Over 300 scientific articles

Education & Training

  • University of Miami/Jackson Health System
    University of Miami/Jackson Health SystemFellowship, Neuromuscular Medicine (Neurology), 1985 - 1987
  • University of Chicago
    University of ChicagoResidency, Neurology, 1982 - 1985
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1981 - 1982
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1981
  • University of Chicago
    University of ChicagoPhD, Behavioral Pharmacology, 1976
  • University of Chicago
    University of ChicagoBS, Biological Sciences, 1967

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 1985 - 2027
  • IL State Medical License
    IL State Medical License 1982 - 1987
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Clinical Investigator Development Award NIH
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
  • Award for Animation entitled "Dancing DNA" Annual Sights and Sounds of Science Project, 2004
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials  
    Biglan, K and Huntington Study Group (with J. Sanchez-Ramos), JAMA Neurology, 1/1/2016
  • Cannabinoids for the Treatment of Movement Disorders  
    Catlow B, Sanchez-Ramos J, Current Treatment Options in Neurology, 1/1/2015
  • Evaluation of an alpha synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson's disease  
    Kenneth E. Ugen, Xiaoyang Lin, Ge Bai, Zhanhua Liang, Jianfeng Caid, Kunyun Li, Shijie Song, Chuanhai Cao & Juan Sanchez-Ramos, Human Vaccines & Immunotherapeutics, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Relationship Between Affective and Cognitive Functioning in At-risk and Presymptomatic Huntington Disease Patients.
    Cimino, CR; Hergert, D; Johnson, P; Sanchez-Ramos, J, Neurotherapeutics, 1/1/2016
  • Effects of Bone Marrow Transplantation in a Mouse Model of HD.
    Song S, Sava V and Sanchez-Ramos J, International Symposium on HD, Venice, Italy, 1/1/2013
  • Nanoparticles for Delivery of DNA and siRNAinto Brain  by Nasal Insufflation
    Sava V, Aradi S, Song S, Sanchez-Ramos J, International Symposium on HD, Venice, Italy, 1/1/2013
  • Join now to see all

Lectures

  • "Nose-to-Brain Delivery of Gene Therapy" 
    Cambridge, MA - 1/1/2014
  • "Art and Science: a Neurologist's Perspective" 
    Tampa Museum of Science and Industry - 1/24/2012
  • "Neon Neurons" 
    St. Petersburg, FL - 1/1/2012
  • Join now to see all

Other

  • Estado Actual de la Hipotesis de Los Oxiradicales en la Enfermedad de Parkinson. 
    Sanchez-Ramos J, Anitoxidantes y Calidad de Vida
    Buenos Aires, Argentina - 1/1/1996
  • Radicales libres y enfermedades neurodegenerativas. 
    Sanchez-Ramos J, Anitoxidantes y Calidad de Vida
    Buenos Aires, Argentina - 1/1/1995
  • Parkinson's Disease Update. 
    Neurology Update, Continuing Medical Education, Corp.
    Princeton - 1/1/1989

Press Mentions

  • University of South Florida Participates in Phase III Clinical Trial Targeting Huntington’s Disease
    University of South Florida Participates in Phase III Clinical Trial Targeting Huntington’s DiseaseSeptember 5th, 2019
  • Neurogenesis Our Foundation of Present ,Past and Future Human Intelligence
    Neurogenesis Our Foundation of Present ,Past and Future Human IntelligenceApril 21st, 2017

Professional Memberships

Other Languages

  • Spanish, French